Antibodies

The National Institutes of Health (NIH), The National Institute of Allergy and Infectious Diseases (NIAID) intends to negotiate on an other than full and open basis with the vendor IBT Bioservices, 4 Research Court, Suite 300, Rockville, Md., 20850 for HTP antibodies. 1). Human anti-EBOV GP mAb (KZ52), Catalog # 0260-001, Qty 10 each, 2). Mouse anti-SUDV GP mAb (16F6), Catalog # 0280-001, Qty 10 each, 3). Chimeric anti-EBOV GP mAb (c13C6 FR1), Catalog # 0201-023, Qty 10 each, 4). Chimeric anti-EBOV GP mAb (h13F6), Catalog # 0201-022, Qty 10 each, 5). Mouse anti-SUDV GP mAb (2H5), Catalog # 0202-029, Qty 10 each, 6). Chimeric anti-EBOV GP mAb (c6D8), Catalog # 0201-021, Qty 3 each, 7). Mouse anti-EBOV GP mAb (4F3), Catalog # 0201-020, Qty 3 each, 8). Mouse anti-MARV GP mAb (2D8), Catalog # 0203-025, Qty 2 each, 9). Mouse anti-MARV GP mAb (5C1), Catalog # 0203-023, Qty 2 each, 10). EBOV Soluble GP (sGP) ELISA Kit, Catalog # 0100-001, Qty 40 each,(Expiration date one year from purchase date), 11). Recombinant EBOV Soluble GP (sGP), Catalog # 0565-001, Qty 4 each and 12). shipping and handling. Items shipped must come from the same lot available at the time of shipment. The statutory authority for this sole source requirement is 41 U.S.C. 253 (c) (1) as implemented by FAR 6.302-1 only one source available, no substitutions possible. THIS IS NOT A REQUEST FOR PROPOSAL. All responsible sources that can provide these products may submit a response that will be considered. All responses in writing shall be submitted to Lawrence Bland Jr. at blandl@mail.nih.gov. All responses received by the closing date will be considered by the Government. A determination not to compete this requirement, based upon responses to this notice, is solely within the discretion of the Government..